<DOC>
	<DOCNO>NCT01775943</DOCNO>
	<brief_summary>Lung cancer lead cause cancer-related death worldwide well know remain major health problem . Non-small-cell lung cancer ( NSCLC ) constitute 80 % case lung cancer . Today , NSCLC define various molecular criterion . Especially , somatic mutation within epidermal growth factor receptor ( EGFR ) gene discover subset NSCLC patient . Two activate EGFR mutation in-frame deletion exon 19 substitution L858R exon 21 , account 85 % clinically important mutation relate EGFR TKI sensitivity . Besides two activate EGFR mutation , EGFR mutation NSCLC discover . G719 L861 report intermediate sensitivity EGFR TKI . And in-frame insertion within exon 20 T790 , know resistant EGFR TKIs . However , still EGFR mutation E709 S768 well doublet EGFR mutation also observe . These rare mutation fully describe data correlation response EGFR-TKIs still unclear . Research hypothesis Rare EGFR mutation unknown clinical significance NSCLC patient , distinguish mutation deletion exon 19 , L858 insertion exon 20 , possibility EGFR TKI sensitivity . Rationale conduct study It opportunity show efficacy EGFR TKIs patient rare EGFR mutation large number patient Korea ( Asia ) short period .</brief_summary>
	<brief_title>Efficacy EGFR TKIs Patients With Rare EGFR-mutated NSCLC</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>1 . Histological confirm nonsmall cell lung cancer ( NSCLC ) , Stage IIIB stage IV , January 1 , 2008 December 31 , 2011 2 . Confirmed EGFR rare mutation ( EGFR mutation except exon 19 deletion exon 21 L858R ) use direct DNA sequence 3 . Experiences treatment EGFR TKIs . 4. least one measurable and/or evaluable lesion accord RECIST criterion ( version 1.1 ) Subjects enter study follow exclusion criterion fulfil : EGFR wild type , EGFR exon 19 deletion alone , EGFR L858R alone</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Epidermal growth factor receptor</keyword>
	<keyword>Mutation</keyword>
	<keyword>Lung cancer</keyword>
	<keyword>Drug sensitivity</keyword>
</DOC>